This compound is an Fmoc-protected amino acid derivative featuring a long aliphatic chain with a terminal alkene. It is primarily used as a building block in solid-phase peptide synthesis, enabling the incorporation of a non-natural amino acid residue.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 945212-26-0
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-methoxy-2-methylphenyl)propanoic acid
pharmaceutical intermediate
(R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-methylheptanoic acid
pharmaceutical intermediate
Fmoc-beta-Alanine
pharmaceutical intermediate
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(1,3-dioxoisoindolin-2-yl)hexanoic acid
pharmaceutical intermediate
5-Bromo-3-chloropyridine-2-carbonitrile
pharmaceutical intermediate
5'-ODMT cET-uridine 3'-OCE amidite
pharmaceutical intermediate
9-(2,5-Anhydro-4-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-3-O-{(2-cyanoethoxy)[di(propan-2-yl)amino]phosphanyl}-6-deoxy-alpha-L-mannofuranosyl)-2-(2-methylpropanamido)-3,9-dihydro-6H-purin-6-one
pharmaceutical intermediate
4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzoic acid
pharmaceutical intermediate
(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methyldec-9-enoic acid
MADFVGMQNXRFAF-AREMUKBSSA-N
C[C@@](CCCCCCC=C)(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13